Skip to main content
. 2020 Jan 23;16:230–237. doi: 10.1016/j.omto.2020.01.004

Table 4.

Correlation between miR-29a Expression and Clinical Parameters

Variables Cases (%) miR-29a
p Value
Low High
Age, 46.80 ± 2.57 0.447

≤47 years 53.3 20 33.3
>47 years 46.7 26.7 20

Tumor Grade 0.512

I 6.7 6.7 0
II 66.7 26.7 40
III 26.7 13.3 13.3

Nuclear Grade 0.348

Low 7.1 7.1 0
High and intermediate 28.6 7.1 21.4
High 64.3 35.7 28.6

Tumor Stage 0.517

T1 40 26.7 13.3
T2 13.3 6.7 6.7
T3 40 13.3 26.7
T4 6.7 0 6.7

Tumor Size (cm) 0.185

≤2 73.3 26.7 40.7
>2 26.7 20 6.7

Area of Invasive Component, 4.09 ± 0.13 cm2 0.143

≤4 66.7 40 26.7
>4 33.3 6.7 26.7

Tumor Side 0.782

Right 53.3 26.7 26.7
Left 46.7 20 26.7

Margin 0.185

Free 73.3 26.7 46.7
Involved 26.7 20 6.7

Prevascular Invasion 0.310

Negative 26.7 6.7 20
Positive 73.3 40 33.3

Preneural Invasion 0.605

Negative 20 6.7 13.3
Positive 80 40 40